38 search results
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 27 Apr 2017
Surgical sampling or removal of low-grade glioma brain tumors
The issue: Low-grade gliomas (LGGs) are slow growing, less aggressive brain tumors. The most optimal surgical management is under debate. The aim of the review: There are two surgical management strategies (treatments) for a person with a suspected LGG. These are biopsy, the surgical sampling of a small amount of tumor tissue, or resection, where ... -
Cochrane EvidencePublished 21 Apr 2017
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma
Review question We reviewed the evidence of the effectiveness and side effects of 131I-meta-iodobenzylguanidine (131I-MIBG) therapy in patients with newly diagnosed high-risk (HR) neuroblastoma (NBL). Background NBL is a rare solid cancer that develops from special nerves cells. Patients with newly diagnosed HR NBL have a poor outcome, despite intensive ... -
Cochrane EvidencePublished 17 Oct 2016
Muscle stimulation for weakness in adults with advanced disease
Background Individual studies suggest that neuromuscular electrical stimulation, or NMES, may help improve the muscle weakness that people often experience as a consequence of a progressive disease. NMES uses a lightweight stimulator unit and skin electrodes to produce a controlled and comfortable muscle contraction. Being a passive form of exercise, ... -
Cochrane EvidencePublished 9 Sep 2016
Anaesthesia with injectable versus gaseous anaesthetic agents for rapid awakening following surgery for brain tumour
Review question: We reviewed and compared evidence on the usefulness of injectable and gaseous techniques for rapid awakening from anaesthesia in people undergoing surgery for brain tumour. Background: Brain tumour surgery is carried out most often with the patient asleep and with the use of injectable agents or gases. Injectable agents are delivered ... -
Cochrane EvidencePublished 19 Aug 2016
Radiation dose escalation for malignant glioma
Background: High grade glioma (HGG) is a rapidly growing brain tumour in the supporting cells of the nervous system, with several subtypes such as glioblastoma (grade IV astrocytoma), anaplastic (grade III) astrocytoma and anaplastic (grade III) oligodendroglioma. It affects about 5 in 100,000 people per year in Europe and North America. A number of ... -
Cochrane EvidencePublished 16 Aug 2016
Interventions for cognitive impairment due to non-localised cancer treatment such as chemotherapy or hormonal therapy
The issue An increasing number of people are surviving and living longer with cancer due to earlier diagnosis, better treatments and an aging population. In turn, there is an increasing number of people with long-term or long-lasting effects of cancer and its treatment. For example, up to seven in 10 cancer survivors experience changes in ability ... -
Cochrane EvidencePublished 14 Jul 2016
Intracystic bleomycin for children with cystic craniopharyngiomas
Craniopharyngiomas are rare, slow-growing, benign tumours in the hypothalamic-pituitary region of the brain. Although they are benign, i.e. the tumour lacks the ability to invade neighbouring tissue or metastasise (spread to other sites), there is considerable morbidity and disability even when the tumour can be resected completely. Cystic craniopharyngiomas ... -
Cochrane EvidencePublished 27 Jun 2016
Radiotherapy for diffuse brainstem glioma in children and young adults
Review question To assess the effects of conventional radiotherapy (with or without chemotherapy) versus other therapies (including different radiotherapy techniques) for newly diagnosed diffuse brainstem gliomas in children and young adults aged 0 to 21 years. Background Diffuse brainstem glioma typically occurs in the pons (part of the brainstem) ... -
Cochrane EvidencePublished 28 Apr 2016
Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy
The issue There is a risk of serious complications developing after radiation treatment (radiotherapy) for cancer (late radiation tissue injury (LRTI)). These problems can be very difficult to resolve and there is some doubt as to the best approaches to treatment. Hyperbaric oxygen therapy (HBOT) involves breathing oxygen in a specially designed chamber. ... -
Cochrane EvidencePublished 13 Apr 2016
Interventions for the management of fatigue in adults with a primary brain tumour
Background A primary brain tumour (PBT) is a cancer that began in the brain rather than spread from other parts of the body. Fatigue (tiredness) is common in people with a PBT. This may be due to the tumour, its treatment or to the use of other medicines such as antiepileptic drugs (which are used to treat epilepsy seizures). It may also occur with ...
